大会主席、中国抗癌协会理事长、中国工程院院士樊代明表示，中国抗癌协会编写的CACA指南通过16 种语言全球传播，在全国建立400多个学科赋能共建单位推动实践落地。协会将以"抗癌-控瘤-保生"为 核心理念，持续向世界传递肿瘤防治的"中国方案"。 辽宁省卫生健康委员会党组书记、副主任陈艳兰表示，辽宁将癌症防治行动纳入"健康辽宁"建设总体布 局，持续深化医改，强化肿瘤防治体系建设。希望以本次大会为契机，汲取国内外专家智慧，同时分享 辽宁在肿瘤防控方面的实践与探索，为全国同行提供参考。 新华网沈阳9月22日电（记者高爽）9月20日至21日，2025CACA东北整合肿瘤学大会在沈阳召开，本届 大会以"肿瘤防治，赢在整合"为主题。 本次会议由中国抗癌协会（CACA）主办，中国整合医学发展战略研究院、世界整合肿瘤学会 （WAIO）共同主办，辽宁省肿瘤医院暨大连理工大学附属肿瘤医院承办，辽宁省抗癌协会、吉林省抗 癌协会、黑龙江省抗癌协会及CACA相关委员会、专委会共同承办。 辽宁省肿瘤医院党委书记刘宏旭表示，随着疾病谱的变化和人民健康需求的提升，传统单一诊疗模式已 难以应对肿瘤这一复杂疾病的挑战。作为东北地区肿瘤防治的重要力 ...

Core Insights - The 28th CSCO Annual Meeting was held in Jinan, Shandong, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Hysco Clinical Oncology Research Foundation, featuring 75 academic sessions and around 1,500 expert speakers, including over 30 international experts from 15 countries [1][2] Group 1: Academic Collaboration - CSCO aims to deepen international cooperation in cancer prevention and treatment, with dialogues planned with high-level representatives from ESMO and other organizations to explore new opportunities [2] - ASCO expressed its commitment to maintaining a strong collaborative relationship with CSCO, emphasizing joint scientific meetings and various initiatives to enhance global oncology development [3] Group 2: Recognition and Awards - CSCO awarded the Annual Achievement Award to three scholars for their significant contributions to clinical oncology, highlighting the importance of innovation and impact in the field [4] - Ten outstanding research papers were recognized, focusing on treatment strategies, new drug development, biomarker exploration, and real-world data analysis, showcasing the depth and innovation of Chinese oncology research [4] Group 3: Academic Content and Innovation - The conference featured 75 academic sessions, emphasizing original research and evidence-based medicine, with a focus on new therapies like ADC and CAR-T/CAR-NK, and addressing major cancer types through AI-focused sessions [6] - The meeting also highlighted the management of cancer as a chronic disease, with a focus on patient quality of life and long-term survival, alongside the release of new clinical guidelines [6] Group 4: Future Directions - The theme of the conference, "Standardized Diagnosis and Treatment, Innovative Leadership," included 530 academic reports and 196 oral presentations, aiming to translate research achievements into clinical practice [7] - The event serves as a key platform for the Chinese oncology community to showcase achievements and foster collaboration, ultimately enhancing cancer prevention and treatment standards in China [7]

通过专科联盟的建立，各方将在肿瘤规范化诊疗、筛查早诊、人才培养及科研协作等领域形成长效机 制，切实提升区域肿瘤防治水平。在实践路径上，联盟将建立双向转诊程序和肿瘤疾病转诊指导目录， 畅通慢性期、恢复期肿瘤疾病患者向下转诊渠道。同时依托专科联盟内医疗机构肿瘤专科医疗资源，以 肿瘤专科协作为纽带，建立联盟内不同级别、不同类别医疗机构间目标明确、权责清晰的分工协作机 制。 8月28日，内蒙古自治区肿瘤专科联盟在呼和浩特正式成立。这一重要举措标志着内蒙古肿瘤防治事业 进入新发展阶段，此举是优化分级诊疗服务、实现"大病不出省"目标的具体实践，将为优化区域医疗资 源布局、提升基层诊疗能力按下"加速键"。 据介绍，联盟由北京大学肿瘤医院内蒙古医院（内蒙古医科大学附属肿瘤医院）牵头组建，依托该院的 优势资源，通过定期派驻专家、远程会诊、标准化培训等方式，快速提升成员单位的诊疗水平，最终将 让内蒙古的百姓在家门口就能享受到优质、高效的肿瘤诊疗服务，切实减轻就医负担，提升健康获得 感。 此外，联盟还将建立肿瘤专科医师进修、规范化培训制度，开展相关培训；依托远程医疗平台，开展远 程讲课、教学查房、病例讨论和学术交流，有力提升基层医 ...

Core Insights - The event marked the recognition of China Resources Pharmaceutical Group as a member of the China Anti-Cancer Association, highlighting the collaboration between the two entities in cancer prevention and treatment [2][4][6] Group 1: Event Overview - The event was themed "Empowerment through Integration" and included a visit to the innovation center of China Resources Pharmaceutical Group, showcasing its patient-centered innovations over 75 years [4][5] - Key figures from the China Anti-Cancer Association, including its president and vice presidents, attended the event, emphasizing the importance of collaboration in cancer treatment [2][6] Group 2: Strategic Initiatives - The China Anti-Cancer Association introduced 17 strategic measures under the guidance of integrated medicine, aiming to enhance cancer prevention and treatment in China [5][6] - The association's "China Cancer Integrated Diagnosis and Treatment Guidelines" established a comprehensive system for cancer care, including over 70 technical guidelines and 60 cancer type guidelines [5][6] Group 3: Industry Collaboration - China Resources Pharmaceutical Group aims to integrate resources across research, education, and application to improve patient access to innovative drugs, positioning itself as a leader in the pharmaceutical distribution sector [6][9] - The company plans to enhance collaboration with the China Anti-Cancer Association to build a new ecosystem for cancer prevention and treatment, supporting the Healthy China strategy [6][9] Group 4: Challenges and Opportunities - The Chinese pharmaceutical industry is entering a new phase driven by product innovation, but faces challenges such as shortened product life cycles and commercialization difficulties [6][9] - The company is leveraging its extensive distribution network and experience to improve patient accessibility and address the challenges in drug availability and payment [6][9]

Group 1: Cancer Prevention and Health Education - The 31st National Cancer Prevention and Control Publicity Week emphasizes the theme "Scientific Cancer Prevention, Healthy Living" [1] - Jiangsu Provincial People's Hospital advocates for a health-centered approach to cancer prevention, focusing on health education and improving public health literacy [1] - The hospital suggests integrating health education into its development plan, establishing dedicated health education departments, and enhancing the scientific literacy of medical staff through training [1] Group 2: Comprehensive Cancer Care - Jiangsu Provincial People's Hospital adopts a multidisciplinary treatment model, establishing specialized centers for lymphoma, gastric tumors, and thyroid cancer to manage patient care throughout the entire process [2] - The hospital has upgraded traditional treatment processes to full-cycle rehabilitation management, incorporating resources from traditional Chinese medicine, nutrition, and rehabilitation [2] - The complexity of lymphoma, with over 100 pathological subtypes, necessitates precise diagnosis and individualized treatment plans, focusing on pre-hospital assessments and post-discharge home management [2] Group 3: Research and Innovation in Cancer Treatment - There is a call for increased research into the mechanisms of lymphoma and drug resistance, as well as the exploration of clinical translation pathways [2] - Advances in basic research have led to the development of innovative therapies such as monoclonal antibodies, bispecific antibodies, and cell therapies, significantly improving clinical outcomes for lymphoma patients [2] - The goal is to translate research and clinical experiences into innovative drugs that effectively serve patients with hematological diseases and lymphomas [2]

Core Viewpoint - The article emphasizes the importance of cancer prevention and control, particularly focusing on gastric cancer, and highlights the upcoming educational initiatives aimed at raising public awareness and improving health outcomes [1]. Group 1: Cancer Prevention and Awareness - The 31st National Cancer Prevention Week will take place from April 15 to 21, 2025, aiming to promote cancer prevention knowledge and encourage individuals to take responsibility for their health [1]. - The "People's Good Doctor · Jinshan Camellia Plan" series will feature experts discussing cancer prevention and treatment, fostering a supportive social atmosphere for cancer control [1]. Group 2: Gastric Cancer Focus - Gastric cancer is identified as a common malignant tumor with high incidence and mortality rates, posing significant challenges to public health and causing substantial suffering for patients and families [1]. - Understanding the causes, symptoms, treatment, and prevention of gastric cancer is crucial for enhancing public health awareness, promoting early detection, and improving patient quality of life [1]. Group 3: Expert Participation - Dr. Chen Xiaobing and Dr. Lu Jun will participate in a live session on April 28, 2025, to address questions related to gastric cancer prevention and treatment [1][2]. - Dr. Chen Xiaobing is a senior physician and a recognized expert in oncology, while Dr. Lu Jun is a vice chief physician with extensive experience in gastric surgery [2]. Group 4: Accessing the Live Session - The live session can be accessed through the People's Good Doctor App, where users can click on the "Famous Doctor Live" section to watch [3]. - Additional health education resources and interactive sessions with top doctors are available through the People's Good Doctor App and the People's Health public WeChat account [4].

Core Viewpoint - The article emphasizes the rising incidence of urinary system tumors in China, particularly prostate, bladder, and kidney cancers, and highlights the importance of early screening, comprehensive treatment, and multidisciplinary collaboration in cancer prevention and control [1][2]. Group 1: Rising Incidence and Risk Factors - The incidence of urinary tumors is positively correlated with economic development and lifestyle changes, especially in coastal eastern regions of China [2] - High-risk groups include elderly males, individuals with a family history, long-term smokers, and those exposed to chemical pollutants [2] - Smoking is closely linked to kidney and bladder cancers, while poor drinking habits and the consumption of carbonated beverages may also contribute to urinary tumors [2] Group 2: Early Detection and Screening Recommendations - Early symptoms of urinary tumors are often subtle and easily overlooked, necessitating regular screenings starting at age 50 for the general population and at 45 for high-risk individuals [3] - Recommended screening methods include PSA testing for prostate cancer, ultrasound, and urinalysis for bladder and kidney cancers, with further diagnostic procedures as needed [3][4] Group 3: Innovations in Treatment - Advances in targeted therapies, immunotherapy, and robotic surgery are providing new hope for patients [5] - Genetic testing can guide precision medicine, such as using PARP inhibitors for prostate cancer patients with BRCA mutations and antibody-drug conjugates for bladder cancer patients with HER2 overexpression [5] - Robotic-assisted surgeries enhance precision in tumor removal while preserving patient quality of life [5] Group 4: Multidisciplinary Collaboration and Standardization - The multidisciplinary treatment (MDT) model is crucial for managing complex cases, requiring collaboration among various medical specialties [6] - The "China Cancer Integrated Diagnosis and Treatment Guidelines" provides a standardized framework for grassroots hospitals [6] - Shandong University Qilu Hospital promotes resource sharing and standardized treatment through academic exchanges and online consultations [6]

今年4月15日至21日为第31个全国肿瘤防治宣传周，今年的主题是"科学防癌 健康生活"。儿童也可能成 为肿瘤患病人群，专家指出，儿童肿瘤在发病机制、类型、治疗方式和预后等方面都有其独特性，初期 症状可谓"五花八门"，部分肿瘤还可能表现为多饮多尿、性早熟等症状，要及早发现儿童肿瘤，家长可 以学习"洗澡自查法"及"睡眠摸肚脐法"。 遗传、基因突变、环境为儿童肿瘤致病因素 儿童肿瘤主要分为血液肿瘤和实体肿瘤两大类。血液肿瘤主要起源于淋巴造血系统，影响骨髓、血液和 淋巴组织，包括白血病和淋巴瘤。实体肿瘤是一组发生在儿童时期的非淋巴造血系统肿瘤，可发生在身 体的各个器官和组织，如中枢肿瘤（髓母细胞瘤、颅内生殖细胞瘤等）、神经母细胞瘤、肾母细胞瘤、 视网膜母细胞瘤及软组织肉瘤等。 哪些原因可导致儿童肿瘤的发生？首都医科大学附属北京儿童医院肿瘤内科副主任、主任医师苏雁介 绍，儿童患肿瘤是多种因素共同作用的结果。目前已知的主要原因包括遗传因素、基因突变和环境因 素。具体来看，某些儿童肿瘤，如视网膜母细胞瘤、胸膜肺母细胞瘤，与遗传性基因突变（如RB1、 DICER1基因）直接相关，虽然携带致病基因并不意味着一定会发病，但患癌风 ...

本次义诊活动是两家医院连续两年联合开展的"全国肿瘤防治宣传周"大型公益行动。中国医学科学 院肿瘤医院辽宁医院副院长吴令英教授在活动中特别强调，针对各类肿瘤疾病，"早期发现、及时治 疗"是关键。她指出，若病情延误至中晚期阶段，不仅治疗费用会成倍增加，疗效也会大打折扣，更会 给患者带来难以承受的身体痛苦和精神压力。此次义诊旨在通过面对面科普宣传，切实提升公众对肿瘤 早期筛查的重视，帮助更多患者家庭避免"发现即晚期"的遗憾境遇。 中国医科大学附属第一医院副院长李凯教授告诉记者，本次活动是两家医院强强联合、惠及百姓的 又一具体实践。"合作三年间，我们共同开展了143项高新诊疗技术，其中区域内领先技术85项，国内领 先技术58项。这些诊疗技术极大地推动了辽宁地区肿瘤诊疗水平的提高，同时加快了科研成果的研发转 化。"李凯说。 2025年4月15日-21日，是第31个全国肿瘤防治宣传周，今年宣传周的活动主题是"科学防癌 健康生 活"。活动旨在通过普及癌症防治科学知识，倡导群众践行健康生活方式，控制癌症风险因素；鼓励高 风险人群主动参加癌症筛查，促进早诊早治；指导癌症患者及时接受规范化诊疗，并定期复查。通过全 过程全生命周期 ...